PDT Partners’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,942
| Closed | -$154K | – | 848 |
|
|
2024
Q4 | $154K | Sell |
13,942
-42
| -0.3% | -$463 | 0.01% | 674 |
|
|
2024
Q3 | $172K | Sell |
13,984
-55
| -0.4% | -$676 | 0.02% | 668 |
|
|
2024
Q2 | $190K | Sell |
14,039
-7,387
| -34% | -$99.8K | 0.02% | 615 |
|
|
2024
Q1 | $289K | Buy |
+21,426
| New | +$289K | 0.03% | 538 |
|
|
2023
Q3 | – | Sell |
-23,592
| Closed | -$251K | – | 680 |
|
|
2023
Q2 | $251K | Sell |
23,592
-12,244
| -34% | -$130K | 0.03% | 483 |
|
|
2023
Q1 | $299K | Sell |
35,836
-4,626
| -11% | -$38.5K | 0.04% | 463 |
|
|
2022
Q4 | $373K | Buy |
40,462
+24,851
| +159% | +$229K | 0.06% | 444 |
|
|
2022
Q3 | $200K | Sell |
15,611
-8,059
| -34% | -$103K | 0.03% | 720 |
|
|
2022
Q2 | $313K | Buy |
+23,670
| New | +$313K | 0.03% | 732 |
|
|
2021
Q3 | – | Sell |
-25,554
| Closed | -$860K | – | 906 |
|
|
2021
Q2 | $860K | Buy |
25,554
+18,897
| +284% | +$636K | 0.06% | 404 |
|
|
2021
Q1 | $259K | Buy |
+6,657
| New | +$259K | 0.02% | 650 |
|